douglas johnson

Displaying 1 - 5 of 5

Twelve at Vanderbilt are among world’s highly cited researchers

Twelve at Vanderbilt are among world’s highly cited researchers

Related Categories: 
Research C. Michael Stein Clarivate Dan Roden De-en Jiang douglas johnson Elizabeth Phillips highly cited researchers James Crowe jeffrey rathmell Justin Balko Mariana Byndloss Mark Denison Web of Science Xiaotao Lu

Five researchers from VUMC among most highly cited

Five from VUMC among most highly cited researchers

Related Categories: 
Research C. Michael Stein Clarivate coronavirus COVID-1 9 Dan Roden Department of Medicine Department of Pediatrics Department of Pharmacology douglas johnson James Crowe Jr. Mark Denison pathology microbiology and immunology Web of Science

Encephalitis identified as rare toxicity of immunotherapy treatment

After a cancer patient receiving an immunotherapy developed encephalitis and died 18 months into treatment, researchers at Vanderbilt-Ingram Cancer Center (VICC) investigated why the complication occurred, performing a molecular analysis of the disease’s pathology and mining data to determine the incidence of similar occurrences.

Related Categories: 
Research cancer immunotherapy checkpoint inhibitors Department of Medicine douglas johnson encephalitis Justin Balko Nature Medicine Vanderbilt Ingram Cancer Center

Immunotherapies linked to specific heart complications

Immunotherapies linked to specific heart complications

Related Categories: 
adverse drug reactions cancer immunotherapy cancer checkpoint inhibitors Department of Medicine douglas johnson immunotherapy James C. Bradford Jr. Melanoma Fund Javid Moslehi NCI NIH The Lancet Oncology Vanderbilt Cardio-Oncology Vanderbilt Ingram Cancer Center

Study tracks incidence, timing of immunotherapy-related deaths

Study tracks incidence, timing of immunotherapy-related deaths

Related Categories: 
checkpoint inhibitors douglas johnson immunotherapy JAMA Oncology NIH Vanderbilt Ingram Cancer Center